trending Market Intelligence /marketintelligence/en/news-insights/trending/y-f5rwkVJxe8XP-At12xRg2 content esgSubNav
In This List

HealthEquity issues fiscal 2020 outlook

Blog

Anticipate the Unknown Go Beyond Fundamentals to Uncover Early Signs of Private Company Credit Deterioration

Blog

Taking Loss Given Default Estimation to the Next Level: An Aspiration for All Creditors, Not Just Banks

Blog

Anticipate the Unknown A Fundamentals Approach to Detect Early Signs of Private Company Credit Deterioration

Blog

Insight Weekly: Banks pursue deals; offshore wind transmission; UK broadcasters vs. streamers


HealthEquity issues fiscal 2020 outlook

HealthEquity Inc. has issued guidance for the fiscal year ending Jan. 31, 2020.

The company anticipates revenue to range from $333 million to $339 million; net income to be between $58 million and $62 million, or between 89 cents and 95 cents per share; non-GAAP net income to range from $80 million to $84 million, or $1.23 to $1.29 per share; and adjusted EBITDA to be between $133 million and $138 million.

For the fiscal year ended Jan. 31, 2019, HealthEquity reported revenue of $287.2 million; net income of $73.9 million, or $1.17 per share; non-GAAP net income of $76 million, or $1.19 per share; and adjusted EBITDA of $118.4 million.

In the fiscal year ended Jan. 31, 2018, the company reported net income of $47.4 million, or 77 cents per share.

HealthEquity reported fiscal fourth-quarter net income of $13.1 million, or 21 cents per share, compared to $5.9 million, or 9 cents per share, in the year-ago period. On a non-GAAP basis, it recorded net income of $17 million, or 27 cents per share.

The S&P Global Market Intelligence consensus normalized EPS estimates for fiscal fourth quarter and fiscal year 2019 were 22 cents and $1.16, respectively.